06/22/2018 “The Ultra-Rapid Insulin (URI) BioChaperone® Lispro (BCLIS) shows Favorable Pharmacodynamics (PD) and Pharmacokinetics (PK) vs Faster Aspart (FIA) and Insulin Aspart (ASP) in Insulin Pumps (CSII)” (Poster 1035), presented by Dr. Bruce W. Bode, 78th Scientific Sessions of the American Diabetes Association, 22-26 June 2018, Orlando, FL (USA)
06/22/2018 “BioChaperone® Lispro, une formulation ultra-rapide d’insuline lispro, améliore le contrôle glycémique post-prandial de sujets diabétiques de type 1 traités par de multiples injections quotidiennes d’insuline pendant 14 jours.” (Abstract CAD-19), presented by Dr. Grégory Meiffren, 2018, Société Francophone du Diabète (France)
06/22/2018 “Ultra-rapid BioChaperone® Lispro ameliorates postprandial blood glucose (PPG) control compared to Humalog in subjects with type 1 diabetes mellitus” (Poster PI005), presented by Dr G. Anderson, American Society for Clinical Pharmacology & Therapeutics (ASCPT)
06/15/2018 Ultra-Rapid BioChaperone® Lispro ameliorates postprandial blood glucose control compared with Humalog(R) in subjects with type 1 diabetes mellitus, Dr. Grit Anderen, 76th Scientific Sessions American Diabetes Association 10-14 June 2016, New Orleans, LO (USA)
06/14/2018 Adocia to Present Six Abstracts at the American Diabetes Association® 78th Scientific Sessions Icon check
06/11/2018 BioChaperone® Combo (BC Combo) improves postprandial glycemia vs. Humalog® Mix 75/25™ (HMx) in people with type 1 diabetes mellitus (T1DM, Dr. Steven V. Edelman, 76th Scientific Sessions American Diabetes Association 11-13 June 2016, New Orleans, LO (USA)
06/08/2018 Number of shares and voting rights of ADOCIA as of May, 31 2018 Icon check
06/05/2018 Adocia to Participate in the Jefferies 2018 Global Healthcare Conference Icon check
06/01/2018 Adocia and Tonghua Dongbao Announce Global Supply Agreements for Insulin Lispro and Insulin Glargine Icon check
05/07/2018 Number of shares and voting rights of ADOCIA as of April, 30 2018 Icon check
05/02/2018 Adocia to hold conference call in regard to the Strategic Alliance for BioChaperone® Combo and BioChaperone® Lispro in China with Tonghua Dongbao Icon check
04/26/2018 Adocia and Tonghua Dongbao Announce a Strategic Alliance for BioChaperone®Combo and BioChaperone® Lispro in China. Icon check
04/19/2018 Adocia announces the release of its Reference Document for the year 2017 Icon check
04/16/2018 Number of shares and voting rights of ADOCIA as of March, 31 2018 Icon check
04/16/2018 Adocia initiates First-in-Human Clinical Study of BioChaperone® Pramlintide Insulin in people with type 1 diabetes Icon check
04/16/2018 Adocia announces first quarter 2018 financial results: Cash position and revenue Icon check
04/09/2018 Adocia to hold its annual shareholders’ meeting on May 17, 2018 in Lyon Icon check
03/19/2018 ADOCIA announced its financial results for 2017 and its perspectives for 2018 Icon check
03/06/2018 Number of shares and voting rights of ADOCIA as of February 28, 2018 Icon check
02/17/2018 BioChaperone® Lispro, an Ultra-Rapid Insulin Lispro formulation improves post-prandial blood glucose control in a 14-day multiple daily insulin injection study in subjects with T2DM, Dr. Grégory Meiffren, February 14-17, 2018, ATTD, Vienna (Austria)
02/14/2018 BioChaperone® Lispro, an Ultra-Rapid Insulin Lispro formulation improves post-prandial blood glucose control in a 14-day multiple daily insulin injection study in subjects with T2DM, Dr. Grégory Meiffren, February 14-17, 2018, ATTD, Vienna (Austria)
02/12/2018 Number of shares and voting rights of ADOCIA as of January 31, 2018 Icon check
02/12/2018 Adocia: additional resources allocated to the liquidity agreement Icon check
02/09/2018 Adocia to Present at the 2018 BIO CEO & Investor Conference in New York Icon check
02/06/2018 Adocia Files Additional Arbitration Claims Against Eli Lilly & Company Icon check
01/25/2018 Adocia Announces Positive Topline Data From a Dose-Proportionality Study of BioChaperone® Combo in People with Type 2 Diabetes Icon check
01/10/2018 Number of shares and voting rights of ADOCIA as of December 31, 2017 Icon check
01/08/2018 Adocia announces its financial calendar for 2018 Icon check
01/04/2018 Adocia announces expanded use of BioChaperone® beyond diabetes Icon check
12/07/2017 Number of shares and voting rights of ADOCIA as of November 30, 2017 Icon check
12/06/2017 Adocia announces positive topline study results comparing ultra-rapid insulin BioChaperone® Lispro with Novolog® and Fiasp® in people with type 1 diabetes Icon check
11/20/2017 Adocia Reports Topline Results of BioChaperone® Glucagon Phase 1 Study Icon check
11/20/2017 “Ultra-rapid BioChaperone® Lispro (BCLIS) Improves Postprandial Blood Glucose (PPG) Excursions vs. Insulin Lispro (LIS) in a 14-Day Treatment Study in Subjects with Type 1 Diabetes (T1DM)” (Poster 964) presented by Dr. Tim Heise, 77th Scientific Sessions of the American Diabetes Association, 9-13 June 2017 in San Diego, CA (USA)
11/08/2017 Number of shares and voting rights of ADOCIA as of October 31, 2017 Icon check
10/20/2017 “Ultra-rapid BioChaperone® Lispro (BCLIS) Improves Postprandial Blood Glucose (PPG) Control vs. Insulin Lispro (LIS) in a14-Day Treatment Study in Subjects with Type 2 Diabetes (T2DM)” (Poster 994) presented by Dr. Tim Heise, 77th Scientific Sessions of the American Diabetes Association, 9-13 June 2017 in San Diego, CA (USA)
10/12/2017 Number of shares and voting rights of ADOCIA as of September 30, 2017 Icon check
09/20/2017 “Proportional Dose-Exposure Relationship of Ultra-rapid BioChaperone® Lispro (BCLIS) in Healthy Japanese Subjects” (Poster 996), presented by Dr. Grégory Meiffren, 77th Scientific Sessions of the American Diabetes Association, 9-13 June 2017 in San Diego, CA (USA)
09/18/2017 Number of shares and voting rights of ADOCIA as of August 31, 2017 Icon check
09/05/2017 Adocia Announces Two Data Presentations at the 53rd Annual Meeting of the European Association for the Study of Diabetes Icon check
07/26/2017 Adocia announces appointment of Dr. Stanislav Glezer as Chief Medical Officer Icon check
07/19/2017 Adocia presents first half 2017 financial results Icon check
07/11/2017 Number of shares and voting rights of ADOCIA as of June 30, 2017 Icon check
06/14/2017 Adocia announces financial results for the third quarter 2017
06/09/2017 Number of shares and voting rights of ADOCIA as of May 31, 2017 Icon check
06/09/2017 “Preclinical Efficacy of a Stable Aqueous Formulation of Human Glucagon with BioChaperone® Technology (BC GLU)” (Poster 1150), presented by Dr Grégory Meiffren, 77th Scientific Sessions of the American Diabetes Association, 9-13 June 2017 in San Diego, CA (USA)
06/09/2017 “Profil pharmacodynamique de BioChaperone® Combo, une co-formulation liquide des insulines lispro et glargine, chez des sujets diabétiques de type 2” (Abstract CAD-19), presented by Dr. Martin Gaudier, 2017, Société Francophone du Diabète (France)
06/09/2017 “L’insuline ultra-rapide BioChaperone® Lispro améliore le contrôle glycémique postprandial par rapport à Humalog® chez des sujets diabétiques de type 1” (Abstract CAD-19), presented by Dr. Grégory Meiffren, 2017, Société Francophone du Diabète (France)
06/09/2017 “BioChaperone® Combo, une co-formulation liquide des insulines lispro et glargine, présente un contrôle glycémique amélioré par rapport à un premix d’insuline.” (Abstract CAD-19), presented by Dr. Claire Megret, 2017, Société Francophone du Diabète (France)
06/07/2017 Adocia Initiates a Phase 1b Clinical Study on the Dose-Proportionality of BioChaperone® Combo in People with Type 2 Diabetes Icon check
06/06/2017 Adocia Announces Positive Topline Results from a Meal-Test Clinical Study of BioChaperone® Combo in People with Type 2 Diabetes Icon check
06/01/2017 Adocia initiates a study comparing ultra-rapid insulin BioChaperone® Lispro U100 with Fiasp® and Novolog® administered with an insulin pump Icon check
06/01/2017 Adocia Launches First-in-Man Clinical Study of BioChaperone® Glucagon Icon check
05/30/2017 Adocia Announces Six Data Presentations at the American Diabetes Association® 77th Scientific Sessions Icon check
05/30/2017 Adocia to Present at the Jefferies 2017 Global Healthcare Conference in New York Icon check
05/19/2017 Adocia to hold its annual shareholders’ meeting on June 27, 2017 in Paris Icon check
05/15/2017 Number of shares and voting rights of ADOCIA as of April 30, 2017 Icon check
04/18/2017 Adocia announces the release of its Reference Document, containing the Annual Financial Report and the Management Report, for the year 2016 Icon check
04/18/2017 Adocia announces first quarter 2017 financial results Icon check
04/13/2017 Number of shares and voting rights of Adocia as of March 31, 2017 Icon check
03/13/2017 Number of shares and voting rights of ADOCIA as of February 28, 2017 Icon check
Join our mailing list. Subscribe